CardFlight Appoints Adam Bloomston to Board of Directors
Payments entrepreneur and operator brings go-to-market leadership and industry expertise
Bloomston was the co-founder of Payscape, helping to build the business through its acquisition by Parthenon Capital, where Payscape's business was a foundational pillar in growing Payroc. Today, Payroc ranks among the top merchant acquirers in
"Adam has a rare blend of payments expertise, operational pragmatism and proven go-to-market leadership," said
"I am excited to join CardFlight's board and support the team as they continue to deliver practical, high-impact payments solutions for SMBs," said Bloomston. "CardFlight has built a strong platform and a great team. I look forward to contributing to the next phase of growth."
"We're grateful to have Adam's leadership experience and perspective on the Board of Directors, as CardFlight continues to scale the number and breadth of small business customers it serves," said
Bloomston also serves on the board of Payroc.
About CardFlight, Inc.
CardFlight, Inc. is the maker of SwipeSimple, a practical payments platform built for how businesses work in the real world. Trusted by more than 125,000+ merchants, SwipeSimple keeps business moving from the field to the front desk to the back office with easy tools for CRM, invoicing and subscriptions, saved cards, installments, recurring payments, payment links, and plain-English reporting. SwipeSimple enables businesses to accept payments anywhere on phone, tablet, computer, or compatible terminals, helping them grow and focus on what they do best–serving their customers.
View original content:https://www.prnewswire.com/news-releases/cardflight-appoints-adam-bloomston-to-board-of-directors-302671048.html
SOURCE CardFlight, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia
- Best Crypto Presale 2026 Heats Up as Korean Fund Commits $30M to XRP-Focused Evernorth and Remittix Builds Toward Launch
- JACC: Clinical Electrophysiology Publishes 12-Month Outcomes from Field Medical's First-in-Human Field PULSE Trial: 94.2% Per-Vein PVI Durability with Optimized Waveform
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share